Genomic alterations of KEAP1/NFE2L2/CUL3(K/N/C) in Chinese lung cancer patients (pts)

被引：0
|
作者：
Qian, C. [1 ]
Wang, C. [2 ]
Wang, X. [2 ]
He, Q. [2 ]
Ma, T. [2 ]
Zhang, X. [2 ]
机构：
[1] Peoples Liberat Army Mil Med Univ, Affiliated Hosp 3, Daping Hosp, Dept Oncol, Chongqing, Peoples R China
[2] Genetron Hlth Beijing Co Ltd, Dept Translat Med, Beijing, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.1308
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2002P
引用
收藏
页码：S1118 / S1118
页数：1
相关论文
共 50 条
  • [31] Association between locoregional failure and NFE2L2/KEAP1/CUL3 pathway mutations in NRG/RTOG 9512: A randomized trial of hyperfractionation vs. conventional fractionation in T2N0 glottic squamous cell carcinoma (SCC).
    Guan, Li
    Torres-Saavedra, Pedro A.
    Zhao, Xiaobei
    Major, Michael B.
    Holmes, Brittany J.
    Nguyen, Ngan
    Kumaravelu, Parasakthy
    Hodge, Tim
    Diehn, Maximilian
    Zevallos, Jose
    Emami, Bahman
    Sagar, Stephen M.
    Morrison, William H.
    Schultz, Christopher J.
    Caudell, Jimmy J.
    Jones, Christopher U.
    Yom, Sue S.
    Harris, Jonathan
    Le, Quynh-Thu
    Hayes, David N.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [32] Phase II study of TAK228 in patients with advanced non-small cell lung cancer (NSCLC) harboring NFE2L2 and KEAP1 mutations.
    Paik, Paul K.
    Ahn, Linda Su Hyun
    Plodkowski, Andrew J.
    Fan, Pang-Dian
    Rudin, Charles M.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [33] PET-Based Radiogenomics Supports KEAP1/NFE2L2 Pathway Targeting for Non-Small Cell Lung Cancer Treated with Curative Radiotherapy
    Bourbonne, V.
    Morjani, M.
    Lucia, F.
    Hatt, M.
    Jaouen, V.
    Querellou, S.
    Visvikis, D.
    Pradier, O.
    Schick, U.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E7 - E8
  • [34] PET/CT-Based Radiogenomics Supports KEAP1/NFE2L2 Pathway Targeting for Non-Small Cell Lung Cancer Treated with Curative Radiotherapy
    Bourbonne, Vincent
    Morjani, Moncef
    Pradier, Olivier
    Hatt, Mathieu
    Jaouen, Vincent
    Querellou, Solene
    Visvikis, Dimitris
    Lucia, Francois
    Schick, Ulrike
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (04) : 630 - 634
  • [35] Inhibition of SIRT1 promotes ultraviolet B induced cataract via downregulation of the KEAP1/NFE2L2 signaling pathway
    Wu, Feiying
    Xia, Xinyu
    Lei, Ting
    Du, Huiying
    Hua, Hui
    Liu, Wei
    Xu, Bin
    Yang, Tianyao
    JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY, 2023, 245
  • [36] KEAP1/NFE2L2 Mutations of Liquid Biopsy as Prognostic Biomarkers in Patients With Advanced Non-Small Cell Lung Cancer: Results From Two Multicenter, Randomized Clinical Trials
    Zhu, Hongyuan
    Xie, Daipeng
    Yu, Yunfang
    Yao, Lintong
    Xu, Bin
    Huang, Luyu
    Wu, Shaowei
    Li, Fasheng
    Zheng, Yating
    Liu, Xinyi
    Xie, Wenzhuan
    Huang, Mengli
    Li, Hao
    Zheng, Shaopeng
    Zhang, Dongkun
    Qiao, Guibin
    Chan, Lawrence W. C.
    Zhou, Haiyu
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [37] NRF2 Pathway Signature Predicts KEAP1/NFE2L2 Mutations and Reveals Alternative Pathway-Activating Mutations in NSCLC
    Arolt, C.
    Dugan, M.
    Wild, R.
    Richartz, V.
    Holz, B.
    Scheel, A. H.
    Braegelmann, J.
    Merkelbach-Bruse, S.
    Wolf, J.
    Buettner, R.
    Lafleur, F.
    Scheffler, M.
    Catanzariti, L.
    Hillmer, A.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S411 - S412
  • [38] Impact on the Clinical Evolution of Patients with COVID-19 Pneumonia and the Participation of the NFE2L2/KEAP1 Polymorphisms in Regulating SARS-CoV-2 Infection
    Elena Soto, Maria
    Fuentevilla-Alvarez, Giovanny
    Palacios-Chavarria, Adrian
    Valdez Vazquez, Rafael Ricardo
    Herrera-Bello, Hector
    Moreno-Castaneda, Lidia
    Estela Torres-Paz, Yazmin
    Janet Gonzalez-Moyotl, Nadia
    Perez-Torres, Idalia
    Aisa-Alvarez, Alfredo
    Manzano-Pech, Linaloe
    Perez-Torres, Israel
    Huesca-Gomez, Claudia
    Gamboa, Ricardo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (01)
  • [39] Molecular Characteristics and Outcome of Chinese Patients with Non-Small Cell Lung Cancer Harboring NFE2L2 Mutations
    Wang, W.
    Xu, C.
    Zhuang, W.
    Song, Z.
    Zhu, Y.
    Chen, R.
    Guan, Y.
    Yi, X.
    Chen, Y.
    Chen, G.
    Fang, M.
    Lv, T.
    Song, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1945 - S1945
  • [40] Survival Outcomes and Treatment Patterns in Patients With NFE2L2 and/or KEAP1 Mutation-Positive Advanced Squamous Cell NSCLC Using a Real-World Clinico-Genomic Database
    Wu, Yanyu
    Yin, Yu
    Crossland, Victoria
    Vincent, Sylvie
    Paik, Paul K.
    Lineberry, Neil
    Faller, Douglas V.
    CLINICAL LUNG CANCER, 2022, 23 (06) : 487 - 497
12345